An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Treatment Gaining Popularity Online
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these accounts directly for source information, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Experts Express Worries
Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals administering products of unknown origin.
Some experts stated the demand for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer laws, risking fines, prosecution or imprisonment.
Platform Reaction and Content Elimination
According to the social media company, the platform has taken down problematic content and banned associated hashtags and query recommendations. The organization said it was dedicated to keeping the service secure and investing in enhancing compliance measures.
Digital Trading Operations
Investigations also discovered communities with up to nine thousand participants selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, populated with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at residence.
After moments of entering one group, a seller shared WhatsApp details, where most purchases take place. The vendor sent an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or previous experience.
Item Information and Pricing
Inside these communities, posts show dark colored packages with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Service Oversight and Security Actions
A representative for the messaging service stated it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they cannot confirm. Even if the science behind retatrutide is valid, these online versions may not include what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.
Her staff has previously seen patients injured by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to potentially serious medical dangers”.
